Exscientia Builds Automated Laboratories in Oxford to Expand Pipeline
August 4, 2021
Exscientia today announced the opening of a 21,000 square foot expansion of its facilities at Oxford Science Park, increasing capacity for its technology teams as well as significantly expanding its laboratory-based experimental capabilities in structural ...
chat_bubble0 Comment
visibility371 Views
Exscientia Accelerates COVID-19 Drug Discovery Using AI
July 8, 2021
Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy Partners, as part of the COVID-19 Therapeutics Accelerator. This is to expedite the optimisation of a new class of COVID-19 ...
chat_bubble0 Comment
visibility222 Views
EQRx and Exscientia Enter Strategic Drug Creation, Development, and Commercialization Collaboration to Accelerate the Advancement of New World-Class Medicines
June 25, 2021
EQRx, a company committed to developing and delivering important new medicines to patients at radically lower prices, and Exscientia, an AI-driven pharmatech company with a mission to radically improve how drugs are discovered, today announced ...
chat_bubble0 Comment
visibility174 Views
Popular Posts
